Methyl iodide → 7-[1-(Pyridin-4-yl)piperidin-4-ylmethoxy]-1,2,3,4-tetrahydroisoquinoline-2-carbothioimidic acid methyl ester

HRID 412517Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 412517
[N:1]1[CH:6]=[CH:5][C:4]([N:7]2[CH2:12][CH2:11][CH:10]([CH2:13][O:14][C:15]3[CH:24]=[C:23]4[C:18]([CH2:19][CH2:20][N:21]([C:25](=[S:27])[NH2:26])[CH2:22]4)=[CH:17][CH:16]=3)[CH2:9][CH2:8]2)=[CH:3][CH:2]=1.Cl.[CH2:29](O)C.CI>CO>[CH3:29][S:27][C:25]([N:21]1[CH2:20][CH2:19][C:18]2[C:23](=[CH:24][C:15]([O:14][CH2:13][CH:10]3[CH2:9][CH2:8][N:7]([C:4]4[CH:5]=[CH:6][N:1]=[CH:2][CH:3]=4)[CH2:12][CH2:11]3)=[CH:16][CH:17]=2)[CH2:22]1)=[NH:26]

Komponenten

5

Reaktionsbedingungen

Temperatur
60 °C

Versuchsvorschrift

7-[1-(Pyridin-4-yl)piperidin-4-ylmethoxy]-1,2,3,4-tetrahydroisoquinoline-2-carbothioamide (200 mg) was treated with hydrogen chloride—ethanol solution. To a suspension of the obtained residue in methanol (6 ml) was added methyl iodide (0.1 ml), and the mixture was stirred at 60° C. for 2 hours. After completion of the reaction, the solvent was evaporated and the obtained residue was dissolved in water and ethanol and neutralized with ion-exchange resin (IRA-410). This was filtrated and the filtrate was concentrated and dried under reduced pressure to give the title compound (200 mg).

Aufarbeitung

  1. customAfter completion of the reaction
  2. customthe solvent was evaporated
  3. dissolutionthe obtained residue was dissolved in water
  4. filtrationThis was filtrated
  5. concentrationthe filtrate was concentrated
  6. customdried under reduced pressure

Quellen und Nachweise

ORD-Eintrag
ord-265c585e5dc649218b60ceeddc3eb872
Quelldatensatz
uspto-grants-2003_05
Patentnummer
US06562828B1

Notizen zur Reaktion

Wird geladen…